Cutera - CUTR Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CUTR shares.
View CUTR analyst ratings or view top-rated stocks.

5 brokerages have issued 12 month target prices for Cutera's stock. Their CUTR share price forecasts range from $33.00 to $70.00. On average, they expect the company's share price to reach $56.20 in the next twelve months. This suggests a possible upside of 55.1% from the stock's current price.
View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts.

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR stock has decreased by 18.1% and is now trading at $36.23.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our CUTR earnings forecast.

Cutera will be holding an earnings conference call on Tuesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Cutera, Inc. (NASDAQ:CUTR) issued its earnings results on Wednesday, November, 3rd. The medical device company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.11. The medical device company earned $57.38 million during the quarter, compared to the consensus estimate of $50.90 million. Cutera had a negative net margin of 31.31% and a negative trailing twelve-month return on equity of 225.70%. During the same quarter last year, the firm earned ($0.13) earnings per share.

Cutera updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $252.00 million-$253.00 million, compared to the consensus revenue estimate of $259.00 million.

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera's stock is owned by many different retail and institutional investors. Top institutional shareholders include Emerald Advisers LLC (1.72%), Emerald Mutual Fund Advisers Trust (1.35%), Essex Investment Management Co. LLC (0.82%), Rice Hall James & Associates LLC (0.39%), Legato Capital Management LLC (0.21%) and Greenwood Capital Associates LLC (0.15%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends.

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CUTR stock can currently be purchased for approximately $36.23.

Cutera (NASDAQ:CUTR) has a market capitalization of $710.47 million and generates $231.27 million in revenue each year. The medical device company earns $2.06 million in net income (profit) each year or ($4.21) on an earnings per share basis.

The company employs 461 workers across the globe.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.